![](/img/cover-not-exists.png)
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
Mudigonda, Tejaswi V., Wyman, Kenneth, Spigel, David R., Dahlman, Kimberly B., Greco, F. Anthony, Puzanov, Igor, Kelley, Mark C., Hainsworth, John D., Sosman, Jeffrey A., Johnson, Douglas B.Volume:
29
Language:
english
Journal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12394
Date:
January, 2016
File:
PDF, 354 KB
english, 2016